Earlier treatment with biologics to reduce the risk of organ damage in systemic lupus erythematosus (SLE) Sponsored by GSK US Medical Affairs

Learn about the importance of reducing organ damage and corticosteroid-associated toxicity in SLE, and how biologics may help to change the course of the disease by targeting its underlying mechanisms.